Certain bottles and doses of duloxetine, a common antidepressant, have been recalled due to the presence of potentially ...

An SNRI (serotonin and norepinephrine reuptake inhibitor) is one of two major classes of medications used to treat clinical ...

Duloxetine is an antidepressant, with a specific batch having been recalled due to the presence of potentially cancer-causing ...

Over 8 million U.S. adults take antidepressants to treat mild to moderate depression, anxiety and, in some cases, chronic ...

The bottles were distributed nationwide, including in Wisconsin, and received the FDA's second-most severe risk ...

More than 233,000 bottles of an antidepressant have been recalled by the FDA due to the presence of duloxetine posing the risk of cancer.

The Food and Drug Administration has recalled Duloxetine, a commonly prescribed antidepressant, due to fears it could contain ...

An antidepressant medication named duloxetine has been recalled by the U.S. Food and Drug Administration (FDA) due to the presence of carcinogenic chemicals. The drug was voluntarily recalled by a ...

For diabetic peripheral neuropathic pain, the recommended dosage is 60 mg per day, although dosages of up to 120 mg daily have been studied. [25] Higher dosages do not have proven benefit and may ...

The recommended dosage of duloxetine is 40 80 mg daily, depending on the indication, preferably split into two doses per day. For the treatment of major depression, duloxetine has achieved ...